Company news
Optibiotix Health Plc (LSE:OPTI) news
Optibiotix Health Plc news releases on 6ix. Latest, Sep 18, 2019: GoFigure® agreement for Southern Africa
Press releases — page 4
GoFigure® agreement for Southern Africa
September 18, 2019
Manufacturing, supply and profit sharing agreement
August 12, 2019
Transfer of certain SkinBioTherapeutics plc shares
July 29, 2019
Online distribution agreement - SlimBiome® Medical
July 18, 2019
Scientific and commercial update
July 11, 2019
License agreement for LPLDL® in Japan
July 3, 2019
LPLDL® license agreement with Kappa Bioscience AS
July 1, 2019
Appointment of goetzpartners securities Limited
June 25, 2019
Manufacturing agreement with Agropur
June 24, 2019
License agreement for CholBiome® in Vietnam
June 10, 2019
Appointment of CEO of ProBiotix Health
May 28, 2019
GoFigure® distribution agreement for Poland
May 22, 2019
License agreement for LPLDL®
May 20, 2019
Distribution Agreement for SlimBiome® in Thailand
May 14, 2019
Investor evening
May 2, 2019
SlimBiome launch to EU market at Vitafoods Europe
May 1, 2019
SlimBiome® Medical launches in UK market
April 24, 2019
SlimBiome® receives approval from FSSAI in India
April 11, 2019
SlimBiome® Medical agreement for Bulgaria
April 9, 2019
SweetBiotix®: Scientific and commercial update
March 27, 2019
Exclusive distribution agreement for SlimBiome®
March 20, 2019
Extension of term and territories for LPLDL®
March 15, 2019
LPLDL® determined GRAS by an Expert Panel in US
February 21, 2019
Presentations at ProBiota - 2019
February 20, 2019
Trading Statement
February 13, 2019
Distribution agreement for LPLDL® in Japan
February 11, 2019
Supply agreement for LPLDL® in the Baltic States
February 7, 2019
Distribution agreement for CholBiome
January 9, 2019
Manufacturing agreement for SlimBiome®
January 7, 2019
Issue of Convertible Loan Notes by ProBiotix
December 14, 2018
SlImBiome® Medical agreement for Greece and Cyprus
December 4, 2018
SlimBiome Medical manufacturing agreement
November 29, 2018
SlimBiome® granted medical device status & CE mark
November 27, 2018
CholBiome® agreement for Greece and Cyprus
November 22, 2018
LPLDL® US manufacturing and supply agreement
October 9, 2018
Exercise of Options & Director's Dealing
October 8, 2018
Non-exclusive distribution agreement for SlimBiome
October 3, 2018
Distribution agreement for CholBiome®
September 26, 2018
Formation of ProBiotix Health Limited
September 24, 2018
Exercise of Warrants and Issue of Equity
September 10, 2018
OptiBiotix signs US pharmaceutical deal
September 4, 2018
Proposed directorate change
August 6, 2018
Director's dealing
July 31, 2018
Agreement with global corporate for SweetBiotix®
June 26, 2018
Exclusive license agreement for LPLDL®
June 21, 2018
Manufacturing agreement with Morley Foods
June 18, 2018
Exercise of Options and Issue of Equity
June 14, 2018
US launch of LPLDL® with Seed Health
June 7, 2018
SweetBiotix® agreement with global dairy company
May 31, 2018
Placing and Issue of Equity
May 30, 2018